Precision Medicine News and Research

RSS

Mologic starts major clinical trial to validate point-of-care COPD exacerbation alert system

Mologic Ltd, a leading developer of lateral flow and rapid diagnostic technologies, today announced that it has started a major clinical trial to validate the Company’s urine-based multi-biomarker self-test, Headstart, for the early detection of exacerbations in patients living with moderate to severe Chronic Obstructive Pulmonary Disease .

6 Dec 2019

Coriell scientist awarded grant to explore epigenetic drivers of breast cancer

Shoghag Panjarian, PhD, a research scientist at the Coriell Institute for Medical Research, has been awarded a grant from the W. W. Smith Charitable Trust to support her search for epigenetic factors that contribute to the development and growth of breast cancer.

5 Dec 2019

ADDF announces new awards through its Diagnostics Accelerator initiative

The Alzheimer's Drug Discovery Foundation announced six new investments totaling $6 million through its Diagnostics Accelerator initiative.

4 Dec 2019

Epigenomic techniques used to fight disease

Humans differ from one another in many ways, including how they react to disease, because of their DNA blueprint, as well as the difference in the environments they face. These factors combine to make each person unique. Now a new study published in the journal Nature Protocols reports the development of a promising technology to uncover the process by which the body fights diseases in different ways.

4 Dec 2019

GW-led consortium receives $2.2 million from FDA for Biocompute Object Specification Project

A consortium led by the George Washington University (GW) has been refunded for their BioCompute Object Specification Project, thanks to a $2.2 million, five-year grant from the U.S. Food and Drug Administration.

4 Dec 2019

FDA-approved drug repairs gut leakiness associated with ulcerative colitis

A research team led by biomedical scientists at the University of California, Riverside, has found that a drug approved by the FDA to treat rheumatoid arthritis and ulcerative colitis can repair permeability defects in the gut's epithelium.

4 Dec 2019

Researchers create new technology to help understand how the body battles diseases

Much remains unknown about diseases and the way our bodies respond to them, in part because the human genome is the complete DNA assembly that makes each person unique. A Virginia Tech professor and his team of researchers have created new technology to help in understanding how the human body battles diseases.

3 Dec 2019

New human colon-on-a-chip enables in vitro study of mucus physiology

We have a mutualistic but complicated relationship with the collection of microbes in our gut known as the intestinal microbiome.

3 Dec 2019

New computational method can help predict and design allosteric functions in proteins

Called the "second secret of life", allostery is one of the most fundamental processes of biology and has been a central focus among scientists across the life sciences spectrum, from fundamental biology to drug development.

3 Dec 2019

Discovery could offer insight into different risk of diseases in African Americans

The percentage of African ancestry in a person's genome determines the level that certain genes are expressed, called mRNA, according to a new Northwestern Medicine study.

3 Dec 2019

Study reveals novel pathway to target colorectal cancer

While the emergence of precision medicine and immunotherapy has greatly improved outcomes for patients with colorectal cancer, new approaches are still needed for patients with late-stage disease who do not respond to these therapies.

26 Nov 2019

Researchers design new antitumoral drug release strategy for breast cancer treatment

The local release of antitumoral drugs through bacterial proteins in the treatment of breast cancer can mark a before and after in precision medicine.

21 Nov 2019

Coriell Institute for Medical Research wins $7.7 million NINDS contract

Coriell Institute for Medical Research has been awarded a $7.7 million contract by the National Institute of Neurological Disorders and Stroke, part of the National Institutes of Health focused on the study of nervous system disorders.

21 Nov 2019

Omega 3 fish oil supplements may benefit some children with ADHD

A team of researchers from King's College London collaborated with colleagues from China Medical University in Taichung, Taiwan to find that omega-3 fish oil supplements could benefit children with Attention Deficit Hyperactivity Disorder (ADHD). Their work was published in the latest issue of the journal Translational Psychiatry.

20 Nov 2019

New gene mutation involved in familial thyroid cancers identified

Researchers from Penn State College of Medicine identified a new gene mutation that may cause a type of familial thyroid cancer.

20 Nov 2019

BGU researchers discover gene that causes nighttime atrial fibrillation

Genetic studies spanning three generations of a Persian Jewish family by researchers at Ben-Gurion University of the Negev. have identified a gene that causes nighttime atrial fibrillation (AFib).

18 Nov 2019

Rare DNA variants linked to sudden cardiac death

Sudden cardiac death affects 220,000 U.S. adults annually, most of whom have no prior symptoms of a heart issue.

17 Nov 2019

Mining 'darkest' parts of the genome in cancer cells yields gold

Mining the rich uncharted territory of the genome or genetic material of a cancer cell has yielded gold for Princess Margaret scientists: new protein targets for drug development against prostate cancer.

15 Nov 2019

Broccoli's effects on kidney health may depend on individual's genetics

New research indicates that the benefits of a dietary compound on kidney health may depend on an individual's genetics. The findings, which appear in an upcoming issue of JASN, may be helpful for tailoring interventions to prevent or treat kidney disease.

15 Nov 2019

Dopamine D2 receptor modulates Wnt expression, controls cell proliferation

The dopamine D2 receptor has a previously unobserved role in modulating Wnt expression and control of cell proliferation, according to a new study from the George Washington University and the University of Pittsburgh.

14 Nov 2019

Precision Medicine News and Research

Mologic starts major clinical trial to validate point-of-care COPD exacerbation alert system

Coriell scientist awarded grant to explore epigenetic drivers of breast cancer

ADDF announces new awards through its Diagnostics Accelerator initiative

Epigenomic techniques used to fight disease

GW-led consortium receives $2.2 million from FDA for Biocompute Object Specification Project

FDA-approved drug repairs gut leakiness associated with ulcerative colitis

Researchers create new technology to help understand how the body battles diseases

New human colon-on-a-chip enables in vitro study of mucus physiology

New computational method can help predict and design allosteric functions in proteins

Discovery could offer insight into different risk of diseases in African Americans

Study reveals novel pathway to target colorectal cancer

Researchers design new antitumoral drug release strategy for breast cancer treatment

Coriell Institute for Medical Research wins $7.7 million NINDS contract

Omega 3 fish oil supplements may benefit some children with ADHD

New gene mutation involved in familial thyroid cancers identified

BGU researchers discover gene that causes nighttime atrial fibrillation

Rare DNA variants linked to sudden cardiac death

Mining 'darkest' parts of the genome in cancer cells yields gold

Broccoli's effects on kidney health may depend on individual's genetics

Dopamine D2 receptor modulates Wnt expression, controls cell proliferation

Event guide: The 4th Precision Medicine in Inflammatory Bowel Disease Summit eBook

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer

Latest News